[
  {
    "ts": "2026-01-09T12:10:43+00:00",
    "headline": "A Look At Bio-Techne (TECH) Valuation After Analyst Downgrade And Softer Cash Flow Concerns",
    "summary": "Bio-Techne (TECH) is back in focus after a recent analyst downgrade that cited softer organic growth and a weaker free cash flow margin, raising fresh questions about how investors should think about the stock today. See our latest analysis for Bio-Techne. Despite the downgrade, Bio-Techne’s share price has held up reasonably well, with a 7 day share price return of 9.8% and a 90 day share price return of 10.1%. However, the 1 year total shareholder return of a 13.6% decline signals that...",
    "url": "https://finance.yahoo.com/news/look-bio-techne-tech-valuation-121043334.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "47328100-bb42-35e4-9bdc-6b1abc7a3e53",
      "content": {
        "id": "47328100-bb42-35e4-9bdc-6b1abc7a3e53",
        "contentType": "STORY",
        "title": "A Look At Bio-Techne (TECH) Valuation After Analyst Downgrade And Softer Cash Flow Concerns",
        "description": "",
        "summary": "Bio-Techne (TECH) is back in focus after a recent analyst downgrade that cited softer organic growth and a weaker free cash flow margin, raising fresh questions about how investors should think about the stock today. See our latest analysis for Bio-Techne. Despite the downgrade, Bio-Techne’s share price has held up reasonably well, with a 7 day share price return of 9.8% and a 90 day share price return of 10.1%. However, the 1 year total shareholder return of a 13.6% decline signals that...",
        "pubDate": "2026-01-09T12:10:43Z",
        "displayTime": "2026-01-09T12:10:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0Ih9Jyeb4E8RAOq22ZtFHA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r5jgPUxQrxmcesBmGBKgkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/look-bio-techne-tech-valuation-121043334.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/look-bio-techne-tech-valuation-121043334.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]